The healthcare system's experiment with independent dispute resolution continues to expand, with the Department of Health and Human Services certifying Physio Solutions, operating as medlitix, as the 17th entity authorized to arbitrate surprise billing conflicts under the No Surprises Act. While the addition addresses capacity concerns, it underscores an uncomfortable reality for health system executives and payers: the dispute resolution infrastructure itself is becoming a battleground where fundamental questions about fairness, consistency, and cost control remain unresolved.
The No Surprises Act, which took effect in 2022, fundamentally reshaped how out-of-network billing disputes are handled. Rather than leaving these conflicts to traditional litigation or direct negotiation, the law created an alternative dispute resolution framework where independent arbitrators—now numbering 17—evaluate claims and determine appropriate payment amounts. The mechanism was designed to protect patients from unexpected bills while creating a structured process for providers and insurers to resolve compensation disagreements.
Yet the rapid expansion of this arbitration network reveals systemic tensions beneath the surface. As more entities gain certification, concerns about consistency have intensified. Researchers have documented significant variations in how different arbiters approach similar cases, raising questions about whether the system delivers predictable, equitable outcomes or simply reflects the particular philosophies of individual arbitrators. For health system CFOs, this unpredictability complicates financial forecasting and budgeting for out-of-network scenarios.
The Arbitration Quality Problem
Lawmakers and academic researchers have begun scrutinizing whether the current framework adequately protects the system's integrity. Critics argue that some arbiters may be too lenient on provider claims, potentially undermining cost-control efforts, while others may systematically favor payers, creating perverse incentives for providers to avoid emergency departments or urgent care centers altogether. Neither outcome serves patients or the broader healthcare ecosystem.
The certification of additional entities like medlitix suggests demand for dispute resolution services is outpacing the supply of qualified arbiters. This could indicate either healthy market growth or a warning sign that the system is becoming overwhelmed. For vendors in the dispute resolution space, the expanding network represents genuine business opportunity, but success will depend on developing processes that gain trust across an increasingly skeptical audience of stakeholders.
Health system leaders should pay close attention to how new arbiters establish their operational standards. Questions worth asking include: What training protocols do they require? How do they handle complex cases involving rare services or geographic variations? What appeals mechanisms exist if outcomes seem unreasonable? The answers will significantly impact organizational exposure to surprise billing arbitration outcomes.
For payers, the expanding IDR network represents both a stabilizing force and a potential liability. More arbiters could reduce processing delays, but only if quality and consistency improve proportionately. The real test will come as regulatory bodies and Congressional committees examine whether the current 17-entity system—and any future expansions—actually serves the law's dual purpose: protecting patients while maintaining rational cost controls.
As the surprise billing landscape matures, the focus must shift from simply adding capacity to ensuring quality. Health system leaders and vendors alike should be preparing for increased scrutiny of arbitration outcomes and potentially more prescriptive guidance about standards from federal regulators.
Reporting basis: healthcaredive.com. Analysis by the HTC editorial desk.